°µ¿°æÈñ´ëº´¿ø ³»ºÐºñ´ë»ç³»°ú Á¤ÀÎ°æ ±³¼ö°¡ ÃÖ±Ù ¿Â¶óÀÎÀ¸·Î °³ÃÖµÈ ¾Æ½Ã¾Æ¿À¼¼¾Æ´Ï¾Æ³»ºÐºñÇмú´ëȸ-¼¿ï±¹Á¦³»ºÐºñÇмú´ëȸ(AOCE-SICEM 2020)¿¡¼ Çмú»óÀ» ¼ö»óÇß´Ù. Á¤ ±³¼ö´Â À̹ø ÇÐȸ¿¡¼ 'Çѱ¹ÀÎ Á¦2Çü ´ç´¢º´ ȯÀÚÀÇ Àú¹Ðµµ Áö´Ü¹é ÄÝ·¹½ºÅ×·Ñ(LDL-C) Ä¡·á ÇöȲ: ÃÖ±ÙÀÇ ÀÌ»óÁöÁúÇ÷Áõ °ü¸® Áöħ°úÀÇ ºñ±³(ACHIEVEMENT OF LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) TARGETS IN PATIENTS WITH TYPE 2 DIABETES IN REAL-WORLD EVIDENCE FROM KOREA: COMPARISON WITH RECENT GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA)'¸¦ ¹ßÇ¥, ¿ì¼öÆ÷½ºÅÍ»óÀ» ¼ö»óÇÏ´Â ¿µ¿¹¸¦ ¾È¾Ò´Ù.
|